A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

NCT01114308 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

287

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Dependency

Interventions

DRUG: Probuphine (buprenorphine implant)
DRUG: placebo implant
DRUG: Buprenorphine

Sponsor

Titan Pharmaceuticals

Collaborators

[object Object]